Search
1135 results:
Innovative medical urine cup for improved analysis of cells in urine  
Kidney disease is one of the most common diseases worldwide, affecting an estimated 10% of the global population. A major challenge in the development of new non-invasive test methods based on urine samples is their limited shelf life. This is only a few hours, as prolonged incubation of the cells in urine leads to cell death and alters the cell…  
LMU Hospital  
 
Ascenion’s portfolio company Captain T Cell closes substantial financing round  
The trial will be led by principal investigator Prof. Antonia Busse, Charité – Universitätsmedizin Berlin, and will be coordinated by National Center for Tumor Diseases (NCT) Berlin, with additional participation from other German NCT sites and the Nuremberg Hospital as an external partner. The study will enroll patients with multiple advanced…  
MHH’s and Fraunhofer ITEM’s iGUARD receives Lower Saxony Innovation Award 2025  
iGUARD emerged as the winner in the category “Knowledge and Technology Transfer” among nearly 100 applications. The project builds on groundbreaking collaborative work by Prof. Axel Schambach and Prof. Adrian Schwarzer at Hannover Medical School (MHH), together with Dr. Philippe Vollmer Barbosa and Prof. Armin Braun at the Fraunhofer Institute for…  
IBA acquires Charité spin-off PhantomX to advance medical imaging  
Founded in 2018 as a spin-off from Charité – Universitätsmedizin Berlin by Dr Paul Jahnke and Dr Felix Schwarz, PhantomX builds on over a decade of research, development and engineering. The company has successfully developed highly realistic anthropomorphic phantoms that improve accuracy and reproducibility in medical imaging, enhance patient…  
Ascenion's Annual Review 2024/25: Focus AI  
Our work is having an impact The white paper on standardization of spin-off conditions in the medical life sciences developed jointly with TransferAllianz and our partners is increasingly being used as a reference. The success of our transfer projects also shows how much we can achieve together. Selected figures from 2024 illustrate this: 34…  
GO-Bio initial Information Webinar by Ascenion  
This interactive session on December 16, 2025, from 11:00 am to 12:30 pm CET will provide you with essential information about funding opportunities, featuring a real-life GO-Bio initial success story. In addition, you will get a preview of our upcoming Life Science Digital Hub Annual Meeting at BioVaria 2026 and have the chance to network…  
Figures and Annual Reviews  
Discover more Ascenion's Annual Reviews Annual Review 2024 Annual Review 2023 Annual Review 2022 Annual Review 2021 Annual Review 2020 Annual Review 2019 Annual Review 2018 Annual Review 2017 Annual Review 2016 Annual Review 2015 Ascenion in figures Innovation. For the benefit of all. Together with our partners in…  
BioVaria 2026 – Save the date!  
Experts from technology transfer, scientists and founders will meet potential licensees and investors from the biotech and pharmaceutical industry during BioVaria 2026 on 27 and 28 April at the Sofitel Munich. The interactive program focuses every year on outstanding development and start-up projects from European research institutes, universities…  
Initiatives  
In the Media "Deutsche Biotech-Gründungen endlich international wettbewerbsfähig" Transfer & Innovation 1/2025, www.transfer-und-innovation.de DUZ Verlags- und Medienhaus GmbH, Berlin   Christian A. Stein im Imagefilm der TransferAllianz   Interview mit Martin Raditsch, CARMA FUND, auf der Plattform Life…  
LifeScience Foundation  
Endowing institutes You can find a list of the endowing institutes on the Foundation's website. See list LifeScience Foundation Unique in Germany Ascenion is a 100% subsidiary of the LifeScience Foundation for the Promotion of Science and Research. This idea of integrating knowledge and technology transfer at academic institutes into a…  
New products from chemical waste using a fungus  
The founders of Biophelion, Till Tiso and Lars Regestein, want to use biotechnological processes to achieve greater sustainability in this material-intensive industry, which has caused massive environmental problems in the past. Their plan is to use the yeast-like fungus Aureobasidium pullulans to convert carbon-containing mixtures of substances…  
New start-up APTA Therapeutics continues research into BC007 for long COVID  
Rovunaptabin (formally BC 007) binds to autoantibodies that target G protein-coupled receptors in the body and neutralizes them. Such antibodies occur in various diseases, including post-COVID syndrome (PCS) – but not in all patients. The drug was developed by the Berlin-based start-up Berlin Cures. An initial case study from 2021 showed that…  
Licensing of technology for improved prediction of preeclampsia  
The PreFree system is an AI-based clinical decision support tool that enables early detection of individual risks for pregnancy complications such as preeclampsia. Preeclampsia is among the most common and dangerous pregnancy complications, responsible for the deaths of approximately 76,000 women and 500,000 unborn children globally each year.…  
New investor capacura for Ascenion’s portfolio company TimeTeller  
TimeTeller GmbH has developed a patented, simple and efficient diagnostic method that precisely records an individual’s circadian rhythm using a saliva test with a digital component. This method is based on the fact that the human body is controlled by its own internal clock, known as the circadian clock. It generates 24-hour rhythms (circadian…  
Ascenion’s portfolio company dotbase develops platform as central workplace in hospitals  
Traditional hospital information systems (HIS) are the backbone of clinical processes. They are fed with data by medical staff, but this data is often only available to individual departments and therefore cannot be used to its full extent to improve patient care. To avoid such data silos, Andrea Kreichgauer and Jasper Mecklenburg founded…  
Ascenion's workshops for the ‘Life Science Digital Hub’  
We regularly offer webinars and workshops as part of our Life Science Digital Hub project (funding code: 03LW0585), which is funded by the German Federal Ministry of Research, Technology and Space (BMFTR) as part of GO-Bio initial. Our 1.5-hour workshops – this quarter on the topic of market analysis – always include a theoretical part, followed…  
Search results 61 until 80 of 1135